Furthermore, Western blot analysis of the NTC-shRNA group revealed that TRI-03 treatment led to decreased levels of XIAP in melanoma tissue, as well as increased cleavage of GSDME and caspase-3 (Figure 6D). The gene discussed is GSDME; the disease is melanoma.